mRNA vaccines can enhance immunotherapy efficacy by activating the immune system, improving outcomes in hard-to-treat tumors. mRNA COVID-19 vaccines enhance immune responses, improving cancer ...

Menopause care is not one-size-fits-all, especially for gender nonconforming individuals, including transgender, nonbinary ...

Serum DR-70 levels are higher in bladder cancer patients, especially in muscle-invasive cases, indicating potential for diagnosis and staging. Current diagnostic methods for bladder cancer are ...

Newly analyzed data from Japan adds to the evidence that COVID-19 may increase the risk of shingles.

Managed Healthcare Executive interviewed OneHome’s Noel Gilliam, Vice President of Value-Based Product Design, to discuss the ...

Veterans who enter the healthcare workforce have a 29% higher chance at promotion and have a 14% higher retention rate than ...

Fenebrutinib shows promise as the first BTK inhibitor for both RMS and PPMS, reducing relapses and slowing disability progression. The FENhance 2 study demonstrated fenebrutinib's efficacy over ...

Patients with advanced melanoma who received fecal microbiota transplants using healthy donor stool alongside standard immunotherapy survived more than four years, according to final results from an ...

Expert discusses how the prevalence of chronic kidney disease (CKD), as reflected by decreased estimated glomerular ...

More than half of melanoma patients whose cancer initially responds to immunotherapy will eventually see their disease return ...

This trial represents the first major advancement in second-line GIST treatment in over two decades, potentially transforming the therapeutic landscape. Cogent Biosciences announced positive results ...

Expert discusses how understanding and promoting awareness of CKD stages enables earlier intervention and better management ...